Abstract:BACKGROUND Serotonin receptor 2B (5-HT2B receptor) plays a critical role in many chronic pain conditions. The possible involvement of the 5-HT2B receptor in the altered gut sensation of irritable bowel syndrome with diarrhea (IBS-D) was investigated in the present study. AIM To investigate the possible involvement of 5-HT2B receptor in the altered gut sensation in rat model and patients with IBS-D. METHODS Rectosigmoid biopsies were collected from 18 patients with IBS-D and 10 patients with irritable bowel syndrome with constipation who fulfilled the Rome IV criteria and 15 healthy controls. The expression level of the 5-HT2B receptor in colon tissue was measured using an enzyme-linked immunosorbent assay and correlated with abdominal pain scores. The IBS-D rat model was induced by intracolonic instillation of acetic acid and wrap restraint. Alterations in visceral sensitivity and 5-HT2B receptor and transient receptor potential vanilloid type 1 (TRPV1) expression were examined following 5-HT2B receptor antagonist administration. Changes in visceral sensitivity after administration of the TRPV1 antagonist were recorded. RESULTS Here, we observed greater expression of the 5-HT2B receptor in the colonic mucosa of patients with IBS-D than in that of controls, which was correlated with abdominal pain scores. Intracolonic instillation of acetic acid and wrap restraint induced obvious chronic visceral hypersensitivity and increased fecal weight and fecal water content. Exogenous 5-HT2B receptor agonist administration increased visceral hypersensitivity, which was alleviated by successive administration of a TRPV1 antagonist. IBS-D rats receiving the 5-HT2B receptor antagonist exhibited inhibited visceral hyperalgesia. Moreover, the percentage of 5-HT2B receptor-immunoreactive (IR) cells surrounded by TRPV1-positive cells (5-HT2B receptor I+) and total 5-HT2B receptor IR cells (5-HT2B receptor IT) in IBS-D rats was significantly reduced by the administration of a 5-HT2B receptor antagonist. CONCLUSION Our finding that increased expression of the 5-HT2B receptor contributes to visceral hyperalgesia by inducing TRPV1 expression in IBS-D patients provides important insights into the potential mechanisms underlying IBS-D-associated visceral hyperalgesia.

Brain-derived Neurotrophic Factor Contributes to Abdominal Pain in Irritable Bowel Syndrome

The Role of Brain-Derived Neurotrophic Factor in Irritable Bowel Syndrome

Effects of heat-sensitive moxibustion on BDNF and TrkB expression in colon of diarrhea-predominat irritable bowel syndrome model rats

BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit

Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain

NR2B contributes to visceral hypersensitivity in irritable bowel syndrome via mBDNF

NR 2 B-containing NMDA receptors contribute to diarrhea-predominant irritable bowel syndrome

Colonic N‐methyl‐d‐aspartate Receptor Contributes to Visceral Hypersensitivity in Irritable Bowel Syndrome

NR2B-containing NMDA receptors contribute to diarrhea-predominant irritable bowel syndrome

The Role of Brain-Derived Neurotrophic Factor in Experimental Inflammation of Mouse Gut.

Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain

Increased Production of BDNF in Colonic Epithelial Cells Induced by Fecal Supernatants from Diarrheic IBS Patients

Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study

Role of Brain-derived Neurotrophic Factor in the Modulation of Post-inflammatory Visceral Hypersensitivity in Mice

EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and plasticity contributing to long-term visceral hypersensitivity in irritable bowel syndrome

Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome

The Brain-Gut Axis Mechanism of Visceral Hypersensitivity of Rats with Irritable Bowel Syndrome

Effect of SB203580 on visceral hypersensitivity in the irritable bowel syndrome rats

Neonatal Colonic Inflammation Sensitizes Voltage-Gated Na+channels Via Upregulation of Cystathionine Β-Synthetase Expression in Rat Primary Sensory Neurons

Expression of NMDAR, CGRP and the Changes of Microglia in Sacral Dorsal Horn of Irritable Bowel Syndrome Rats

Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: A role in pain symptom generation?